These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33542390)

  • 61. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Is otolithic vertigo accompanied by hearing loss caused by sacculocochlear endolymphatic hydrops?
    Murofushi T; Komiyama S; Hayashi Y; Yoshimura E
    Acta Otolaryngol; 2016; 136(1):38-42. PubMed ID: 26399733
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical features and management of Meniere's disease patients with drop attacks.
    Wu Q; Li X; Sha Y; Dai C
    Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):665-672. PubMed ID: 30604056
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Management of intractable Ménière's disease after intratympanic injection of gentamicin.
    Rah YC; Han JJ; Park J; Choi BY; Koo JW
    Laryngoscope; 2015 Apr; 125(4):972-8. PubMed ID: 25363447
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Surgical capping of superior semicircular canal dehiscence.
    Mueller SA; Vibert D; Haeusler R; Raabe A; Caversaccio M
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1369-74. PubMed ID: 23640386
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cochlear-Internal Canal and Cochlear-Facial Dehiscence: A Novel Entity.
    Garaycochea O; Domínguez PD; Manrique M; Manrique-Huarte R
    J Int Adv Otol; 2018 Aug; 14(2):334-336. PubMed ID: 30256207
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Non-ampullary plugging of the posterior semicircular canal for benign paroxysmal positional vertigo.
    Pace-Balzan A; Rutka JA
    J Laryngol Otol; 1991 Nov; 105(11):901-6. PubMed ID: 1761943
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Endolymphatic hydrops perspectives 2012.
    Pierce NE; Antonelli PJ
    Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):416-9. PubMed ID: 22902416
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hearing and Vestibular Function After Preoperative Intratympanic Gentamicin Therapy for Vestibular Schwanomma as Part of Vestibular Prehab.
    Tjernström F; Fransson PA; Kahlon B; Karlberg M; Lindberg S; Siesjö P; Magnusson M
    Ear Hear; 2016; 37(6):744-750. PubMed ID: 27438868
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Results in caloric test, video head impulse test and inner ear MRI in patients with Ménière's disease.
    Kitano K; Kitahara T; Ito T; Shiozaki T; Wada Y; Yamanaka T
    Auris Nasus Larynx; 2020 Feb; 47(1):71-78. PubMed ID: 31272843
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Results of electrocochleography in Ménière's disease after successful vertigo control by single intratympanic gentamicin injection.
    Büki B; Platz M; Haslwanter T; Jünger H; Avan P
    Audiol Neurootol; 2011; 16(1):49-54. PubMed ID: 20523039
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Delayed endolymphatic hydrops].
    Giannoni B; Pagnini P; Vannucchi P
    Acta Otorhinolaryngol Ital; 1998 Aug; 18(4 Suppl 59):66-70. PubMed ID: 10205936
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
    Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of Meniere's disease with simultaneous triple semicircular canal occlusion and cochlear implantation.
    Xiao Q; Wu Q; Zhang Q; He J; Liu Y; Shen J; Lv J; Duan M; Lopez-Escamez JA; Yang J; Zhang Q
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1603-1608. PubMed ID: 38150022
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Extent of lesions in idiopathic sudden hearing loss with vertigo: study using click and galvanic vestibular evoked myogenic potentials.
    Iwasaki S; Takai Y; Ozeki H; Ito K; Karino S; Murofushi T
    Arch Otolaryngol Head Neck Surg; 2005 Oct; 131(10):857-62. PubMed ID: 16230586
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intralabyrinthine Vestibular Schwannoma Responsive to Intratympanic Gentamicin Treatment.
    Covelli E; Volpini L; Filippi C; Tarantini S; Marrone V; Monini S; Barbara M
    J Int Adv Otol; 2017 Aug; 13(2):285-288. PubMed ID: 28816698
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Delayed endolymphatic hydrops: an analysis of 12 cases].
    Casani A; Fattori B; Berrettini S; De Ciccio M; Vannucci G; Ghilardi PL
    Acta Otorhinolaryngol Ital; 1993; 13(4):297-303. PubMed ID: 8135101
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Endolymphatic hydrops in superior canal dehiscence and large vestibular aqueduct syndromes.
    Sone M; Yoshida T; Morimoto K; Teranishi M; Nakashima T; Naganawa S
    Laryngoscope; 2016 Jun; 126(6):1446-50. PubMed ID: 26525170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.